Eutectic mixtures containing the active pharmaceutical ingredient ezetimibe: Phase diagrams, solid state characterization and dissolution profiles

• Published in: Journal of crystal growth Vol. 642; p. 127775
• Main Authors: Yuri Gerônimo Kobata, Pedro, Ticona Chambi, Julian, Maria do Espirito Santo, Ana, Lucia Cuffini, Silvia
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 15-09-2024
• Subjects: A1. Dissolution profiles; A1. Eutectic; A1. Phase diagram; A1. Tamman diagram; B1. Ezetimibe; B1. Ezetimibe; A1. Phase diagram; A1. Tamman diagram; A1. Dissolution profiles; A1. Eutectic
• ISSN: 0022-0248; 1873-5002
• DOI: 10.1016/j.jcrysgro.2024.127775

•Eutectic systems of Ezetimibe with Methylparaben, Salicylic Acid and Nicotinamide.•Phase and Tamman diagrams and structural analyses of Ezetimibe eutectics.•Ezetimibe eutectics improved dissolution rates and hygroscopic stability.
Cardiovascular disease represents the leading cause of death worldwide, according to the World Health Organization (WHO) report. One of the treatment strategies is the use of the drug ezetimibe (EZT). This drug is a cholesterol absorption inhibitor with low aqueous solubility, which affects its therapeutic efficacy. The purpose of this paper was to obtain eutectic materials of EZT with methylparaben (MPB), salicylic acid (SCA) and nicotinamide (NTM) coformers, and to study their phase diagrams, dissolution properties and hygroscopicity to assess possible enhancements. Phase and Tamman diagrams were constructed using differential scanning calorimetry (DSC) results. The eutectic materials were characterized by powder X-ray diffraction (PXRD) and polarized light optical microscopy (OM). The hygroscopicity of the materials was assessed at different relative humidities (RH) through dynamic vapor sorption (DVS). The dissolution study was conducted with the materials in powder form, with paddle dissolution, rotating at 50 rpm, in 900 mL of aqueous buffer solution at pH 6.8 and 37 °C. The phase diagrams demonstrated that EZT formed eutectic systems with eutectic molar fractions of 0.59, 0.67 and 0.69 for EZT-SCA, EZT-NTM and EZT-MPB, respectively. The three eutectic materials are characterized as microcrystalline conglomerates of their components. In terms of the hygroscopic behavior of EZT at different RHs, eutectic materials demonstrated lower susceptibility to monohydrate formation compared to the anhydrous form. In dissolution studies, EZT-SCA and EZT-MPB solubilized EZT in amounts 22 % higher than the pure drug in 15 min. On the other hand, EZT-NTM eutectic suppressed the dissolution of EZT down to 56 % at the same time. The results indicated the possibility of obtaining materials with enhanced properties using eutectic mixtures, with improved dissolution rates and hygroscopic stability.